Scientific publications

Scientific articles authored by Novo Nordisk

The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.

4335 results found.
Showing results 101-120
Journal Author Year
Journal of Medical Genetics

Evidence of an association between genetic variation of the coactivator PGC-1 beta and obesity

Andersen G ; Wegner L ; Yanagisawa K ; Rose CS ; Lin J ; Glumer C ; Drivsholm T ; Borch-Johnsen K ; Jorgensen T ; Hansen T ; Spiegelman BM ; Pedersen O 2005
British Journal of Pharmacology

Effect of acute and long-term treatment with 17-beta- estradiol on the vasomotor responses in the rat aorta

Andersen HL ; Weis JU ; Fjalland B ; Korsgaard N 1999
Journal of Biological Chemistry

2-(Oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases

Andersen HS ; Iversen LF ; Jeppesen CB ; Branner S ; Norris K ; Rasmussen HB ; Moller KB ; Moller NPH 2000
Journal of Medicinal Chemistry

Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B

Andersen HS ; Olsen OH ; Iversen LF ; Sorensen ALP ; Mortensen SB ; Christensen MS ; Branner S ; Hansen TK ; Lau JF ; Jeppesen L ; Moran EJ ; Su J ; Bakir F ; Judge L ; Shahbaz M 2002
Biochemical Journal

Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling

Andersen JN ; Elson A ; Lammers R ; Romer J ; Clausen JT ; Moller KB ; Moller NPH 2001
Faseb Journal

A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage

Andersen JN ; Jansen PG ; Echwald SM ; Mortensen OH ; Fukada T ; Del Vecchio R ; Tonks NK ; Moller NPH 2004
Molecular and Cellular Biology

Structural and evolutionary relationships among protein tyrosine phosphatase domains

Andersen JN ; Mortensen OH ; Peters GH ; Drake PG ; Iversen LF ; Olsen OH ; Jansen PG ; Andersen HS ; Tonks NK ; Moller NPH 2001
Research in Microbiology

Using inactivated microbial biomass as fertilizer: the fate of antibiotic resistance genes in the environment

Andersen JT ; Schafer T ; Jorgensen PL ; Moller S 2001
Bioorganic and Medicinal Chemistry

Synthesis of novel GABA uptake inhibitors. Part 6: Preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives

Andersen KE ; Lau J ; Lundt BF ; Petersen H ; Huusfeldt PO ; Suzdak PD ; Swedberg MDB 2001
Journal of Medicinal Chemistry

Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates

Andersen KE ; Sorensen JL ; Huusfeldt PO ; Knutsen LJS ; Lau J ; Lundt BF ; Petersen H ; Suzdak PD ; Swedberg MDB 1999
Journal of Medicinal Chemistry

Synthesis of novel gamma-aminobutyric acid (GABA) uptake inhibitors. 5. Preparation and structure-activity studies of tricyclic analogues of known GABA uptake inhibitors

Andersen KE ; Sorensen JL ; Lau J ; Lundt BF ; Petersen H ; Huusfeldt PO ; Suzdak PD ; Swedberg MDB 2001
Journal of Clinical Endocrinology and Metabolism

Variation of the McKusick-Kaufman gene and studies of relationships with common forms of obesity

Andersen KL ; Echwald SM ; Larsen LH ; Hamid YH ; Glumer C ; Jorgensen T ; Borch-Johnsen K ; Andersen T ; Sorensen TIA ; Hansen T ; Pedersen O 2005
Clinical Biochemistry

A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies

Andersen L ; Jorgensen PN ; Jensen LB ; Walsh D 2000
Journal of Biological Chemistry

Antibody-induced Enhancement of Factor VIIa Activity through Distinct Allosteric Pathways

Andersen LM ; Andreasen PA ; Svendsen I ; Keemink J ; Ostergaard H ; Persson E 2012
Pharmacology Biochemistry and Behavior

Specific behavioral effects related to age and cerebral ischemia in rats

Andersen MB ; Zimmer J ; Sams-Dodd F 1999
International Journal of Mass Spectrometry

Structural characterization of both the non-proteolytic and proteolytic activation pathways of coagulation Factor XIII studied by hydrogen-deuterium exchange mass spectrometry

Andersen MD ; Faber JH 2011
Biological Chemistry

Coagulation factor XIII variants with altered thrombin activation rates

Andersen MD ; Kjalke M ; Bang S ; Lautrup-Larsen I ; Becker P ; Andersen AS ; Olsen OH ; Stennicke HR 2009
Cytochrome P450, Pt C

Use of methylotropic yeast Pichia pastoris for expression of cytochromes P450

Andersen MD ; Moller BL 2002
Pediatric Diabetes

Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes

Andersen MLM ; Vaziri-Sani F ; Delli A ; Porksen S ; Jacobssen E ; Thomsen J ; Svensson J ; Petersen JS ; Hansen L ; Lernmark A ; Mortensen HB ; Nielsen LB 2012
Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences

Determination of ragaglitazar, a novel dual acting peroxisome proliferator-activated receptor (PPAR) alpha and -gamma agonist, in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry

Andersen MP ; Nielsen KK 2003